Covered recipient · General Payments record
KATIE KERLIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$7,043.58
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $4,250.00 | 1 |
| Food and Beverage | $1,072.13 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $4,674.34 | 8 |
| Recor Medical Inc | $566.01 | 7 |
| Abbott Laboratories | $63.22 | 2 |
| ShockWave Medical, Inc | $18.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $34.87 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125031045 | CMS |
| Abbott Laboratories | $28.35 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125031048 | CMS |
| ABIOMED | $27.07 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142234558 | CMS |
| ABIOMED | $149.17 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142234626 | CMS |
| ABIOMED | $23.23 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142234652 | CMS |
| ABIOMED | $4,250.00 | 11/14/2024 | Honoraria | Undisputed | 01/23/2026 | 1142234874 | CMS |
| ABIOMED | $125.82 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142234888 | CMS |
| ABIOMED | $59.97 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142234890 | CMS |
| ABIOMED | $15.29 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142234892 | CMS |
| ABIOMED | $23.79 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142234884 | CMS |
| Recor Medical Inc | $120.40 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127685414 | CMS |
| Recor Medical Inc | $10.97 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127686979 | CMS |
| Recor Medical Inc | $95.75 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127687135 | CMS |
| Recor Medical Inc | $122.02 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127687577 | CMS |
| Recor Medical Inc | $106.49 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127688357 | CMS |
| Recor Medical Inc | $24.94 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127688381 | CMS |
| Recor Medical Inc | $85.44 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127688391 | CMS |
| ShockWave Medical, Inc | $18.56 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153011171 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.